Navigation Links
New biomarker may predict leukemia aggressiveness
Date:4/19/2009

Scientists at the University of California, San Diego and the Moores UCSD Cancer Center have evidence of a potential new biomarker to predict the aggressiveness of an often difficult-to-treat form of leukemia. They found that high levels of a particular enzyme in the blood are an indicator that chronic lymphocytic leukemia (CLL) the most common form of adult leukemia will be aggressive and in need of immediate treatment.

The researchers, led by Paul A. Insel, MD, professor of pharmacology and medicine at the UC San Diego School of Medicine, say that the enzyme, PDE7B, is also critical to the development of CLL and a potential target for drugs against the disease. They present their results April 19, 2009 at the AACR 100th Annual Meeting 2009 in Denver.

One of the problems in deciding on the right therapy for CLL is that it is difficult to know which type of leukemia a patient has. One form progresses slowly, with few symptoms for years while the other form is more aggressive and dangerous. While tests exist and are commonly used to help doctors predict which form a patient may have, their availability and usefulness are limited.

In previous work, Insel's group had discovered that among a group of enzymes, cyclic nucleotide phosphodiesterases, one of the phosphodiesterases, PDE7B, was 10 times higher in CLL patients than in healthy individuals. PDE7B controls the levels of cyclic AMP (cAMP), a molecule that can promote programmed cell death, a process that is defective in CLL. Whereas most cancers have out-of-control cell growth, CLL is characterized by an overabundance of white blood cells that do not die when they should. High levels of PDE7B mean less cAMP and as a result, less cell death.

"The question was, could the level of PDE7B expression provide evidence for the clinical stage and diagnosis for individual patients?" Insel said. To find out if changes in PDE7B levels might reflect disease progression, Insel, postod
'/>"/>

Contact: Steve Benowitz
sbenowitz@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1 2

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. Penn School of Medicine receives $2.3 million to study biomarkers of cigarette smoke exposure
3. Study makes progress in zoning in on biomarkers for better colon cancer treatment
4. New Ovarian Cancer Biomarker Research Act Introduced
5. Mayo Clinic study points to a possible biomarker for colon cancer in people 50 and under
6. Singulex Announces Presentation on Monitoring of Cardiac Biomarker to Assess Transient Myocardial Ischemia at the American Heart Association Scientific Sessions
7. Biomarker may be an early predictor of advanced breast cancer
8. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
9. Biomarkers predict risk for invasive breast cancer years before the tumor develops
10. JDRF and Lilly partner to fund research to identify beta cell biomarkers
11. Biomarkers for Alzheimers disease can be trusted in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Wohl Associates of Bohemia, NY, specialists ... taken delivery of used industrial pasta machinery from Toresani ... equipment for producing gnocchi and tortelloni. , The mixers ... La Parmigiana mixer/extruder. With a 2.2 kW (5 HP) ... is 17” wide, 28” long and 23” deep that ...
(Date:9/23/2014)... OR (PRWEB) September 23, 2014 Humans do ... their waste water as they could says leading waste water ... Grigg advocated a program in which 100% of all water ... as pure as when it was removed. Solid waste removed ... to the environment. Grigg explained his Total Water Management (TWM) ...
(Date:9/23/2014)... Rosa, CA (PRWEB) September 23, 2014 On ... the arrival of the most technically advanced horticultural LED grow ... it again with the XL750 and XL1000 ... as well as the experienced horticulturalist, because it has what ... the light spectrum. Kind LED's grower-tested 12 band spectrum (also ...
(Date:9/23/2014)... (PRWEB) September 23, 2014 A ... and Digestive and Kidney Diseases has found ... more cases of adults and children developing kidney stones. ... 2005 - 2011 across several U.S. cities, including Dallas, ... that patients usually sought treatment for kidney stones within ...
(Date:9/23/2014)... Hope For The Warriors® is excited ... be hosted in Boston, Massachusetts on Sunday, November 9, ... signature event honors the courage of our wounded service ... Proceeds from the evening will benefit Hope For The ... of self, restoring the family unit, and restoring hope ...
Breaking Medicine News(10 mins):Health News:Used Industrial Pasta Machinery Now Available at Wohl Associates 2Health News:Leading Water Treatment Expert Calls for 100% Waste Water Recycling 2Health News:Leading Water Treatment Expert Calls for 100% Waste Water Recycling 3Health News:Kind LED K5 Series XL1000 Grow Lights Sell Out in Only 2 Days 2Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 2Health News:New Study Finds Link Between Higher Temperatures and Kidney Stones in the United States 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Boston 2Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Boston 3
... so many problems in our health care delivery,system and ... are having problems getting care as well as paying ... Health & Science University,family physician. The study, "Insurance Plus ... Health Care Access for Low Income,Families," recently was published ...
... in the world over 300 families are being recruited ... the treatment of childhood eczema. , The independent trial ... received funding of nearly 1million from the Department of ... Assessment (HTA) programme. The study will focus on hard ...
... a CT scan, and the masses look benign, they ... recent study conducted by researchers at Brown University in ... CT, we are frequently encountering findings that are not ... called incidentalomas, of which adrenal masses are quite common, ...
... to Evaluate Ultra-Pure Ethyl EPA-Niacin ... Treatment of Niacin- Induced Flushing, LONDON, November 29 ... has commenced a phase I clinical,safety and efficacy trial in ... and niacin on niacin induced,flushing. Flushing is a common side ...
... 29 Diabetes Response,Service, the first and only ... and Canada December 1st, 2007 providing scheduled,daily phone ... subscribers to,prevent hypoglycemia and complications such as seizures, ... provides customizable,scheduled text message reminders to help manage ...
... Nov. 29 As part of its HIV,Testing ... for,leading experts on HIV/AIDS issues including HIV screening, ... women., In September 2006, Centers for Disease ... screening that called for,voluntary opt-out screening to be ...
Cached Medicine News:Health News:New study shows low-income families face 3 barriers to health care 2Health News:New study shows low-income families face 3 barriers to health care 3Health News:Eczema sufferers test out benefits of water softeners 2Health News:Eczema sufferers test out benefits of water softeners 3Health News:Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program 2Health News:Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program 3Health News:Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program 4Health News:Amarin Commences First Clinical Trial in Cardiovascular ProgramAmarin Commences First Clinical Trial in Cardiovascular Program 5Health News:Diabetes Response Service Launches in U.S. and Canada 2Health News:Experts Available to Discuss World AIDS Day, HIV/AIDS Issues Facing America 2
(Date:9/23/2014)... 2014 Enable Injections , developer of ... it easy and nearly painless for patients to self-inject ... has been named winner of the ,Buzz of BIO ... biotech sector.    Enable is one of only ... number of votes in the "Late Stage Leaders" category.  ...
(Date:9/23/2014)... Sept. 23, 2014   BioLife Solutions , Inc. ... and marketer of proprietary clinical grade hypothermic storage ... precision thermal shipping products for cells and tissues  ... to its Scientific Advisory Board.  The new members are ... , PhD. Dr. Acker is a Senior ...
(Date:9/23/2014)... LONDON , September 23, 2014 ... pharmaceutical assets, announces the appointment of Jarrod ... role, Mr Longcor is responsible for structuring, negotiating ... financial investments, as well as providing management and ... member of the Executive leadership team. ...
Breaking Medicine Technology:Innovative Wearable Injector Developer, Enable Injections, Wins 'Buzz of BIO Investor Forum' 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 2BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 3BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 4BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 5BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 6BioLife Solutions Announces the Addition of Jason Acker, MBA, PhD and Anthony Davies, PhD to its Scientific Advisory Board 7Avillion Appoints Jarrod Longcor as Chief Business Officer 2
... May 26, 2011 Rigel Pharmaceuticals, Inc. ... of its previously announced underwritten public offering of 16,300,000 ... of $8.00 per share to the public. The gross ... be approximately $130,400,000, before deducting underwriting discounts and commissions, ...
... Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP ) ... amount of senior unsecured notes. The notes will be unsecured, ... certain of the Company,s subsidiaries.   Endo intends ... cash on hand and borrowings under its new credit facility, ...
Cached Medicine Technology:Rigel Announces Pricing of Public Offering of Common Stock 2Rigel Announces Pricing of Public Offering of Common Stock 3Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes 2
... ENA Multiparameter Kit is designed ... six of the most common ... unique quality control system. The ... well in each strip gives ...
Inquire...
Microalbumin Linearity Control...
The K-ASSAY Lp(a) Control Set is intended for use as an assayed quality control material for monitoring the performance of Lp(a) immunoturbidimetric assays....
Medicine Products: